The biggest increase in 2-year survival associated with Medicaid expansion was among patients with stage III disease, with a ...

Doctors worry that Medicaid limits on addiction drug dosing could drive some patients back toward the drugs they're trying to ...

The presidential election, loss of higher federal funding, inflationary pressures and other challenges are leaving state ...

The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Conservative planning and continued business growth helped Molina keep an ongoing mismatch between payment rates and member ...

A decrease appeared to end this summer as enrollment was virtually unchanged in July and slightly increased in August. But ...

A s the annual Medicare open enrollment period unfolds, millions of Americans are evaluating their healthcare options for the ...

New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...

Providers in many states can expect Medicaid reimbursement increases next year. Health insurance companies also are seeking ...

Medicaid expansion improved 2-year survival rates and access to guideline-concordant treatment for patients with HR-negative ...